共 121 条
[1]
Torres A(2013)Risk factors for community-acquired pneumonia in adults in Europe: a literature review Thorax. 68 1057-1065
[2]
Peetermans WE(2018)Burden of pneumococcal community-acquired pneumonia in adults across Europe: a literature review Respir Med 137 6-13
[3]
Viegi G(2017)Penicillin treatment for patients with community-acquired pneumonia in Denmark: a retrospective cohort study BMC Pulm Med 17 66-208
[4]
Blasi F(2014)Prediction of pneumonia 30-day readmissions: a single-center attempt to increase model performance Respir Care 59 199-147
[5]
Torres A(2018)Determining best outcomes from community-acquired pneumonia and how to achieve them Respirology. 23 138-18
[6]
Cilloniz C(2014)Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia BMJ Open Respir Res 1 e000038-764
[7]
Blasi F(2008)The correct approach to community-acquired pneumonia in immunocompetent adults: review of current guidelines New Microbiol 31 1-59
[8]
Chalmers JD(2016)Etiology and risk factors of community-acquired pneumonia in hospitalized patients in Norway Clin Respir J 10 756-e67
[9]
Gaillat J(2015)Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway BMC Infect Dis 15 64-13
[10]
Dartois N(2014)Diagnosis and management of community and hospital acquired pneumonia in adults: summary of NICE guidance BMJ 349 g6722-15